Bifogade filer
Kurs & Likviditet
Kalender
2024-11-13 | Kvartalsrapport 2024-Q3 |
2024-08-07 | Kvartalsrapport 2024-Q2 |
2024-05-24 | Ordinarie utdelning PHO 0.00 NOK |
2024-05-23 | Årsstämma 2024 |
2024-05-15 | Kvartalsrapport 2024-Q1 |
2024-02-21 | Bokslutskommuniké 2023 |
2023-11-08 | Kvartalsrapport 2023-Q3 |
2023-08-09 | Kvartalsrapport 2023-Q2 |
2023-05-10 | Kvartalsrapport 2023-Q1 |
2023-05-04 | Ordinarie utdelning PHO 0.00 NOK |
2023-05-03 | Årsstämma 2023 |
2023-02-24 | Bokslutskommuniké 2022 |
2023-02-23 | Bokslutskommuniké 2022 |
2022-11-02 | Kvartalsrapport 2022-Q3 |
2022-08-10 | Kvartalsrapport 2022-Q2 |
2022-05-11 | Kvartalsrapport 2022-Q1 |
2022-04-29 | Ordinarie utdelning PHO 0.00 NOK |
2022-04-28 | Årsstämma 2022 |
2022-02-23 | Bokslutskommuniké 2021 |
2021-11-17 | Kvartalsrapport 2021-Q3 |
2021-08-11 | Kvartalsrapport 2021-Q2 |
2021-07-28 | Extra Bolagsstämma 2021 |
2021-05-21 | Ordinarie utdelning PHO 0.00 NOK |
2021-05-20 | Årsstämma 2021 |
2021-05-19 | Kvartalsrapport 2021-Q1 |
2021-03-03 | Bokslutskommuniké 2020 |
2020-11-10 | Kvartalsrapport 2020-Q3 |
2020-08-18 | Kvartalsrapport 2020-Q2 |
2020-06-11 | Ordinarie utdelning PHO 0.00 NOK |
2020-06-10 | Årsstämma 2020 |
2020-05-07 | Kvartalsrapport 2020-Q1 |
2020-02-27 | Bokslutskommuniké 2019 |
2019-11-07 | Kvartalsrapport 2019-Q3 |
2019-08-07 | Kvartalsrapport 2019-Q2 |
2019-06-19 | Extra Bolagsstämma 2019 |
2019-05-14 | Kvartalsrapport 2019-Q1 |
2019-05-10 | Ordinarie utdelning PHO 0.00 NOK |
2019-05-09 | Årsstämma 2019 |
2019-02-27 | Bokslutskommuniké 2018 |
2018-11-08 | Kvartalsrapport 2018-Q3 |
2018-08-08 | Kvartalsrapport 2018-Q2 |
2018-05-23 | Kvartalsrapport 2018-Q1 |
2018-05-11 | Ordinarie utdelning PHO 0.00 NOK |
2018-05-09 | Årsstämma 2018 |
2018-02-27 | Bokslutskommuniké 2017 |
2017-11-08 | Kvartalsrapport 2017-Q3 |
2017-08-23 | Kvartalsrapport 2017-Q2 |
2017-05-23 | Kvartalsrapport 2017-Q1 |
2017-04-28 | Ordinarie utdelning PHO 0.00 NOK |
2017-04-27 | Årsstämma 2017 |
2017-02-15 | Bokslutskommuniké 2016 |
2016-11-15 | Kvartalsrapport 2016-Q3 |
2016-08-23 | Kvartalsrapport 2016-Q2 |
2016-05-10 | Kvartalsrapport 2016-Q1 |
2016-04-29 | Ordinarie utdelning PHO 0.00 NOK |
2016-04-28 | Årsstämma 2016 |
2016-02-11 | Bokslutskommuniké 2015 |
2015-10-29 | Kvartalsrapport 2015-Q3 |
2015-08-13 | Kvartalsrapport 2015-Q2 |
2015-05-06 | Kvartalsrapport 2015-Q1 |
2015-05-02 | Ordinarie utdelning PHO 0.00 NOK |
2015-04-30 | Årsstämma 2015 |
2015-02-12 | Bokslutskommuniké 2014 |
2014-11-06 | Kvartalsrapport 2014-Q3 |
2014-08-26 | Kvartalsrapport 2014-Q2 |
2014-05-28 | Ordinarie utdelning PHO 0.00 NOK |
2014-05-27 | Årsstämma 2014 |
2014-05-07 | Kvartalsrapport 2014-Q1 |
2014-02-27 | Bokslutskommuniké 2013 |
2013-10-23 | Kvartalsrapport 2013-Q3 |
2013-08-22 | Kvartalsrapport 2013-Q2 |
2013-05-23 | Ordinarie utdelning |
2013-05-22 | Årsstämma 2013 |
2013-04-25 | Kvartalsrapport 2013-Q1 |
2013-02-28 | Bokslutskommuniké 2012 |
2012-10-26 | Kvartalsrapport 2012-Q3 |
2012-08-24 | Kvartalsrapport 2012-Q2 |
2012-05-10 | Årsstämma 2012 |
2012-04-26 | Kvartalsrapport 2012-Q1 |
2012-02-16 | Bokslutskommuniké 2011 |
2011-10-26 | Kvartalsrapport 2011-Q3 |
2011-08-18 | Kvartalsrapport 2011-Q2 |
2011-04-27 | Kvartalsrapport 2011-Q1 |
2011-04-27 | Årsstämma 2011 |
2011-02-17 | Bokslutskommuniké 2010 |
2010-10-27 | Kvartalsrapport 2010-Q3 |
2010-08-19 | Kvartalsrapport 2010-Q2 |
2010-04-28 | Kvartalsrapport 2010-Q1 |
2010-02-19 | Bokslutskommuniké 2009 |
2009-11-26 | Bonusutdelning |
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Medicinteknik |
Oslo, Norway, 31 August 2020.
Participants in Photocure ASA's ("Photocure") share option program have on 31 August 2020 exercised a total of 17,366 options, distributed as follows:
- 9,100 options exercised according to the option program for 2016 at a strike price of NOK 40.15,
- 5,766 options exercised according to the option program for 2017 at a strike price of NOK 38.06, and
- 2,500 options exercised according to the option program for 2019 at a strike price of NOK 50.72.
Share options are described in note 7 in Photocure's annual financial statements for 2019.
Following the exercise, the Board of Directors, pursuant to authorization granted by the company's Annual General Meeting, has decided to increase the company's share capital by NOK 8,683.00 by issuing 17,366 new shares, each with a par value of NOK 0.50. Subsequent to the transaction Photocure's share capital will be NOK 13,313,693 divided into 26,627,386 shares. No primary insiders have exercised options in this window.
For further information, please contact:
Photocure CFO Erik Dahl
Tel: +47 450 55 000
Email: ed@photocure.com
About Photocure ASA
Photocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, making cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered in Oslo, Norway and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit us at www.photocure.com, www.hexvix.com, www.cysview.com
This information is subject to the disclosure requirements pursuant to sections 5-12 and 4-2 of the Norwegian Securities Trading Act.